MTEXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
MANNATECH INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$8.74+1.62 (+22.67%)
Close on Oct 19, 2026
- Market cap
- $16.87M
- P/E (TTM)
- –
- Dividend yield
- –
MANNATECH INC revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $106.00M | $115.90M | – | – | – | – | – | – | – | – | 98.1% | -8.5% |
| Product and Service, Other [Member] | $1.60M | $1.50M | – | – | – | – | – | – | – | – | 1.5% | +6.7% |
| Associate Service Fees [Member] | $400.00K | $500.00K | – | – | – | – | – | – | – | – | 0.4% | -20.0% |
| Consolidated pack sales and associate fees | – | $4.10M | $5.60M | $6.20M | $8.00M | $4.20M | $2.30M | $2.50M | $14.20M | $26.70M | – | – |
| Other | – | $1.50M | $1.10M | $800.00K | $800.00K | $1.00M | $800.00K | $900.00K | $4.60M | $5.00M | – | – |
| Product sales | – | $112.30M | $125.30M | $130.20M | $151.00M | $146.20M | $154.60M | $170.20M | $157.90M | $148.60M | – | – |
By region
From the segment and revenue-disaggregation notes of Mannatech's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.